HEMATOLOGIC MALIGNANCIES
Clinical trials for HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant method offers hope for blood cancer patients
Disease control TerminatedThis study tested a bone marrow transplant using partially matched donors and a milder chemotherapy preparation for people with blood cancers. The goal was to see if this approach could improve survival at 180 days after transplant. The study was terminated early after enrolling …
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 16, 2026 23:37 UTC
-
New drug combo aims to prevent transplant complications in blood cancer patients
Disease control TerminatedThis early-stage study tested whether adding the drug itacitinib to standard anti-rejection medicines could safely prevent graft-versus-host disease (GVHD) in 84 people with blood cancers receiving a stem cell transplant. The main goal was to see if blood cell recovery was normal…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 13, 2026 16:00 UTC